NIH

Vanderbilt researchers have developed tools to probe the role of the essential metal manganese in neurons, and which offer a started point for developing therapeutic agents for manganese-related neurological disorders. Read More

Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease. Read More

A family of single-celled organisms that thrive in environments too extreme for most other species to survive may be an untapped source of new antibacterial drugs. Read More

Vanderbilt researchers will play a key role in the second phase of the federal "tissue chip for drug screening" program. Read More

Martin Blakely, M.D., M.S., has been awarded a $3 million federal grant for a multi-center, multi-disciplinary study to examine the safety outcomes of early versus later inguinal hernia repair for premature infants. Read More

A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics. Read More

Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response. Read More

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial. Read More

The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells. Read More

Nearly 25 percent of all breast cancers among premenopausal women occur within two to five years following a pregnancy. Read More